161 related articles for article (PubMed ID: 37403334)
1. Artificial neural network-based diagnostic models for lung cancer combining conventional indicators with tumor markers.
Luo Y; Yuan H; Pei Q; Chen Y; Xian J; Du R; Ye T
Exp Biol Med (Maywood); 2023 May; 248(10):829-838. PubMed ID: 37403334
[TBL] [Abstract][Full Text] [Related]
2. Early Screening of Colorectal Precancerous Lesions Based on Combined Measurement of Multiple Serum Tumor Markers Using Artificial Neural Network Analysis.
Ke X; Liu W; Shen L; Zhang Y; Liu W; Wang C; Wang X
Biosensors (Basel); 2023 Jun; 13(7):. PubMed ID: 37504084
[TBL] [Abstract][Full Text] [Related]
3. The effect of artificial neural network model combined with six tumor markers in auxiliary diagnosis of lung cancer.
Feng F; Wu Y; Wu Y; Nie G; Ni R
J Med Syst; 2012 Oct; 36(5):2973-80. PubMed ID: 21882004
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the application value of seven tumor-associated autoantibodies in non-small cell lung cancer based on machine learning algorithms].
Hao Y; Wu LN; Lyu YT; Liu YZ; Qin XS; Zheng R
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Nov; 57(11):1827-1838. PubMed ID: 38008573
[No Abstract] [Full Text] [Related]
5. [Establishment of artificial neural network model for predicting lymph node metastasis in patients with stage Ⅱ-Ⅲ gastric cancer].
Xue Z; Lu J; Lin J; Huang CM; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Zheng CH
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Apr; 25(4):327-335. PubMed ID: 35461201
[No Abstract] [Full Text] [Related]
6. [Value of Combined Detection of Cytokines and Tumor Markers in the
Differential Diagnosis of Benign and Malignant Solitary Pulmonary Nodules].
Shi J; Liu X; Ming Z; Li W; Lv X; Yang X; Wang Y; Zhang M; Yang S
Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):426-433. PubMed ID: 34157802
[TBL] [Abstract][Full Text] [Related]
7. Application of artificial neural network model combined with four biomarkers in auxiliary diagnosis of lung cancer.
Duan X; Yang Y; Tan S; Wang S; Feng X; Cui L; Feng F; Yu S; Wang W; Wu Y
Med Biol Eng Comput; 2017 Aug; 55(8):1239-1248. PubMed ID: 27766520
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and prediction of lung cancer through different classification techniques with tumor markers].
Nie GJ; Feng FF; Wu YJ; Wu YM
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2009 May; 27(5):257-61. PubMed ID: 19538834
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of three data mining techniques in diagnosis of lung cancer.
Li D; Li Z; Ding M; Ni R; Wang J; Qu L; Wang W; Wu Y
Eur J Cancer Prev; 2021 Jan; 30(1):15-20. PubMed ID: 32868638
[TBL] [Abstract][Full Text] [Related]
10. Early detection and stratification of lung cancer aided by a cost-effective assay targeting circulating tumor DNA (ctDNA) methylation.
Wang Z; Xie K; Zhu G; Ma C; Cheng C; Li Y; Xiao X; Li C; Tang J; Wang H; Su Z; Liu D; Zhang W; Huang Y; Tang H; Liu R; Li W
Respir Res; 2023 Jun; 24(1):163. PubMed ID: 37330511
[TBL] [Abstract][Full Text] [Related]
11. [Clinical value of tumor-associated autoantibodies in diagnosis of early non-small cell lung cancer].
Ren Z; Ding HM; Qian X; Pan SY
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1426-1434. PubMed ID: 34963239
[No Abstract] [Full Text] [Related]
12. Diagnostic value of circulating genetically abnormal cells to support computed tomography for benign and malignant pulmonary nodules.
Yang H; Chen H; Zhang G; Li H; Ni R; Yu Y; Zhang Y; Wu Y; Liu H
BMC Cancer; 2022 Apr; 22(1):382. PubMed ID: 35397524
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic Value of Serum Pepsinogen Ⅰ/Pepsinogen Ⅱ Combined with Tumor Markers for
Wang SS; Guo ZP; Zhao XY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):186-191. PubMed ID: 36647665
[TBL] [Abstract][Full Text] [Related]
14. A combined diagnostic model based on circulating tumor cell in patients with solitary pulmonary nodules.
Wang D; Li P; Fei X; Che S; Li J; Xuan Y; Wang J; Han Y; Gu W; Wang Y
J Gene Med; 2023 Sep; 25(9):e3529. PubMed ID: 37194408
[TBL] [Abstract][Full Text] [Related]
15. A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules.
Xing W; Sun H; Yan C; Zhao C; Wang D; Li M; Ma J
BMC Cancer; 2021 Mar; 21(1):263. PubMed ID: 33691657
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer.
Li Y; Tian X; Gao L; Jiang X; Fu R; Zhang T; Ren T; Hu P; Wu Y; Zhao P; Yang D
Cancer Med; 2019 Jul; 8(8):3782-3792. PubMed ID: 31132233
[TBL] [Abstract][Full Text] [Related]
17. [Predictive value of combined detection tumor markers in the diagnosis of lung cancer].
Zhang T; Xiang B; Lin YP
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Jun; 55(6):786-791. PubMed ID: 34139821
[TBL] [Abstract][Full Text] [Related]
18. Application of logistic regression and convolutional neural network in prediction and diagnosis of high-risk populations of lung cancer.
Yuan H; Gao Z; He X; Li D; Duan S; Effah CY; Wang W; Wang J; Qu L; Wu Y
Eur J Cancer Prev; 2022 Mar; 31(2):145-151. PubMed ID: 33859129
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of exhaled carbonyl compounds distinguishes benign from malignant pulmonary disease.
Bousamra M; Schumer E; Li M; Knipp RJ; Nantz MH; van Berkel V; Fu XA
J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1074-80; discussion 1080-1. PubMed ID: 25129599
[TBL] [Abstract][Full Text] [Related]
20. Neural network-based computer-aided diagnosis in distinguishing malignant from benign solitary pulmonary nodules by computed tomography.
Chen H; Wang XH; Ma DQ; Ma BR
Chin Med J (Engl); 2007 Jul; 120(14):1211-5. PubMed ID: 17697569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
